(Q51986192)

English

Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine.

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

attenuated vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cristiana Iosef

6

0 references

10

object named as

Linda J Saif

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

author name string

Trang V Nguyen

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Lijuan Yuan

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Marli S P Azevedo

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Kwang-Il Jeong

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Ana M Gonzalez

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Karin Lovgren-Bengtsson

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Bror Morein

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

Peggy Lewis

9

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

24

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

13

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

2302-2316

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

New vaccines to fight killer rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Tetravalent rhesus rotavirus vaccine in young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Ecological studies, rotavirus vaccination, and intussusception.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Natural rotavirus infection is not associated to intussusception in Mexican children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Rotavirus vaccines: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Epidemiological features of rotavirus infection in Caracas, Venezuela: implications for rotavirus immunization programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Human Rotavirus Type 2: Cultivation in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Comparative studies of the pathogenesis, antibody immune responses, and homologous protection to porcine and human rotaviruses in gnotobiotic piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Role of maternally derived circulating antibodies in protection of neonatal swine against porcine group A rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Adoptive transfer of natural antibodies to non-immunized chickens affects subsequent antigen-specific humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Maternal antibody blocks humoral but not T cell responses to BVDV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Regulation of VH gene repertoire and somatic mutation in germinal centre B cells by passively administered antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

Pediatric viral gastroenteritis during eight years of study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.11.043

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16361002

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51986192&oldid=1382090433"